Assignee
SUMITOMO PHARMA CO LTD
JP·61 granted patents·64 pending applications·42 citations·filing 1987–2025
Top patents by PatentIndex Score
125 records- 0191US11911466B2Substituted pyrimidines as vaccine adjuvantsSUMITOMO PHARMA CO LTD·Filed 2022·Granted Feb 27, 2024·1 cites·27 claims
- 0291US11401261B22-heteroaryl aminoquinazolinone derivativeSUMITOMO PHARMA CO LTD·Filed 2021·Granted Aug 2, 2022·2 cites·18 claims
- 0390US11564920B25-heteroaryl-1H-pyrazol-3-amine derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Jan 31, 2023·2 cites·18 claims
- 0489US11911381B2Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Feb 27, 2024·1 cites·15 claims
- 0588US11759509B2WT1 antigen peptide conjugate vaccineSUMITOMO PHARMA CO LTD·Filed 2018·Granted Sep 19, 2023·2 cites·13 claims
- 0687US12440560B2Substituted pyrimidines as vaccine adjuvantsSUMITOMO PHARMA CO LTD·Filed 2024·Granted Oct 14, 2025·0 cites·7 claims
- 0787US11371016B2Method for producing retinal tissueSUMITOMO PHARMA CO LTD·Filed 2017·Granted Jun 28, 2022·4 cites·22 claims
- 0887US2026053911A1Pyrimidine compoundSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 0987US2025332166A1Treatment of prostate cancerSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 1086US12077546B2Bicyclic pyridine derivativeSUMITOMO PHARMA CO LTD·Filed 2023·Granted Sep 3, 2024·2 cites·25 claims
- 1186US11718592B2Oxadiazole derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Aug 8, 2023·1 cites·30 claims
- 1284US11628169B2Therapeutic drug for motor complications in Parkinson's diseaseSUMITOMO PHARMA CO LTD·Filed 2021·Granted Apr 18, 2023·1 cites·24 claims
- 1383US11833247B2Vaccine adjuvant formulationSUMITOMO PHARMA CO LTD·Filed 2022·Granted Dec 5, 2023·1 cites·18 claims
- 1483US11795195B2Antibody-drug conjugates including hemiasterlin derivativeSUMITOMO PHARMA CO LTD·Filed 2018·Granted Oct 24, 2023·2 cites·24 claims
- 1583US2026078115A1Aliphatic acid amide derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 1681US12263167B2Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2024·Granted Apr 1, 2025·0 cites·19 claims
- 1780US12221625B2Method for producing retinal pigment epithelial cellsSUMITOMO PHARMA CO LTD·Filed 2023·Granted Feb 11, 2025·0 cites·24 claims
- 1880US12172987B2Nitrogen-containing saturated heterocyclyl derivativeSUMITOMO PHARMA CO LTD·Filed 2023·Granted Dec 24, 2024·0 cites·30 claims
- 1979US12077510B2Carboxylic acid compoundsSUMITOMO PHARMA CO LTD·Filed 2022·Granted Sep 3, 2024·0 cites·4 claims
- 2079US11618883B2Method for producing retinal pigment epithelial cellsSUMITOMO PHARMA CO LTD·Filed 2018·Granted Apr 4, 2023·1 cites·17 claims
- 2178US11731960B2Biheterocyclic compoundSUMITOMO PHARMA CO LTD·Filed 2022·Granted Aug 22, 2023·0 cites·17 claims
- 2278US11649432B2Method for producing retinal pigment epithelial cellsSUMITOMO PHARMA CO LTD·Filed 2016·Granted May 16, 2023·1 cites·24 claims
- 2378US2025382282A1Nitrogen-containing saturated heterocyclyl derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 2478US2025084090A1Substituted lactams showing serotonin 5-ht receptor activitySUMITOMO PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 2577US2023399308A12,6-disubstituted pyridine derivativeSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 2676US12398125B2Nitrogen-containing saturated heterocyclyl derivativeSUMITOMO PHARMA CO LTD·Filed 2023·Granted Aug 26, 2025·0 cites·43 claims
- 2776US11925621B2Medicinal preparation for external useSUMITOMO PHARMA CO LTD·Filed 2019·Granted Mar 12, 2024·1 cites·13 claims
- 2876US11466007B2Substituted lactams showing serotonin 5-HT receptor activitySUMITOMO PHARMA CO LTD·Filed 2019·Granted Oct 11, 2022·1 cites·31 claims
- 2975US12398149B2Dihydrochromene derivativesSUMITOMO PHARMA CO LTD·Filed 2023·Granted Aug 26, 2025·0 cites·9 claims
- 3075US2026042775A1Crystalline forms of n-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyureaSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 3174US12150941B2Process for preparing substituted pyrazolo[1,5-a]pyrazinesSUMITOMO PHARMA CO LTD·Filed 2023·Granted Nov 26, 2024·0 cites·6 claims
- 3272US12291720B2Production method for retinal tissueSUMITOMO PHARMA CO LTD·Filed 2022·Granted May 6, 2025·0 cites·18 claims
- 3372US12180213B2Substituted pyrazoles showing serotonin 5-HT receptor activitySUMITOMO PHARMA CO LTD·Filed 2022·Granted Dec 31, 2024·0 cites·31 claims
- 3472US2025177395A1Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 3572US2024059732A1Antibody-Drug Conjugates Including Hemiasterlin DerivativeSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 3671US12020824B2Virtual reality video reproduction apparatus, and method of using the sameSUMITOMO PHARMA CO LTD·Filed 2022·Granted Jun 25, 2024·0 cites·12 claims
- 3771US11535599B2Benzisoxazole derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Dec 27, 2022·0 cites·28 claims
- 3871US2024355433A1Clinical trial site selection and interactive visualizationSUMITOMO PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 3970US12000844B2Diagnostic drug and diagnostic method for Alzheimer's diseaseSUMITOMO PHARMA CO LTD·Filed 2019·Granted Jun 4, 2024·1 cites·17 claims
- 4070US11780820B22,6-disubstituted pyridine derivativeSUMITOMO PHARMA CO LTD·Filed 2021·Granted Oct 10, 2023·0 cites·40 claims
- 4170US11495358B2Virtual reality video reproduction apparatus, and method of using the sameSUMITOMO PHARMA CO LTD·Filed 2021·Granted Nov 8, 2022·0 cites·14 claims
- 4270US11440905B2Biheterocyclic compoundSUMITOMO PHARMA CO LTD·Filed 2020·Granted Sep 13, 2022·0 cites·21 claims
- 4370US2023240994A1Medicament-containing hollow particleSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 4470US2026035379A1Bicyclic pyridine derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 4570US2026022109A15-heteroaryl-1h-pyrazol-3-amine derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 4669US11661397B21,4-disubstituted imidazole derivativeSUMITOMO PHARMA CO LTD·Filed 2020·Granted May 30, 2023·0 cites·7 claims
- 4769US2026027114A1Medicament for treating cancer comprising optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 4869US2024293521A1Combination use of wt1 antigen peptide and immunomodulatorSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 4968US2023287009A1Oxo-substituted compoundSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 5067US2023298707A1Systems and methods for clinical trial results endpoint-based analysis and dynamic aggregationSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
Showing the top 50 of 125 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SUMITOMO PHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →